Hostname: page-component-78c5997874-m6dg7 Total loading time: 0 Render date: 2024-11-05T04:46:46.402Z Has data issue: false hasContentIssue false
  • English
  • Français

Transhepatic atrial septal defect closure: simple way to achieve haemostasis in a patient with important co-morbidities

Published online by Cambridge University Press:  08 July 2020

Raymond N. Haddad Open the ORCID record for Raymond N. Haddad [Opens in a new window] ,
Geert Maleux Open the ORCID record for Geert Maleux [Opens in a new window] ,
Damien Bonnet Open the ORCID record for Damien Bonnet [Opens in a new window]  and
Sophie Malekzadeh-Milani Open the ORCID record for Sophie Malekzadeh-Milani [Opens in a new window]
Raymond N. Haddad*
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
Geert Maleux
Affiliation:
Department of Radiology, University Hospitals Leuven, Leuven, Belgium
Damien Bonnet
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
Sophie Malekzadeh-Milani
Affiliation:
M3C-Necker, Hôpital Universitaire Necker-Enfants malades, Université de Paris, Paris, France
*
Author for correspondence: Dr. Raymond N. Haddad, MD, Unité médicochirurgicale de cardiologie congénitale et pédiatrique, centre de référence des malformations cardiaques congénitales complexes – M3C, Hôpital universitaire Necker-Enfants malades, 149, rue de Sèvres, 750015Paris, France. Tel.: +33 7 53 15 95 04; +961 70 605 800; Fax: +33 1 44 49 47 30. E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Percutaneous closure is the gold standard treatment for atrial septal defects, but the procedure can be complex in case of femoral thrombosis. Although unusual for congenital interventionists, transhepatic atrial septal defect closure is an attractive alternative to the internal jugular vein, especially when approaching the interatrial septum. Herein, we report the case of an adult patient with significant co-morbidities who had successful transhepatic atrial septal defect closure after a failed transjugular attempt. We describe the use of an absorbable haemostatic gelatin sponge to efficiently and safely achieve haemostasis after the use of a large vascular sheath with combined anticoagulation and antiplatelet therapy.

Keywords

Atrial septal defectcardiac catheterisationdevice closuretranshepatic accesshaemostasis
Type
Brief Report
Information
Cardiology in the Young , Volume 30 , Issue 9 , September 2020 , pp. 1343 - 1345
Copyright
© The Author(s), 2020. Published by Cambridge University Press

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Shim, D, Lloyd, TR, Cho, KJ, Moorehead, CP, Beekman, RH 3rd. Transhepatic cardiac catheterization in children. Evaluation of efficacy and safety. Circulation 1995; 92: 1526–1530.CrossRefGoogle ScholarPubMed
Cools, B, Rega, F, Gewillig, M.Transhepatic implant of a trimmed Melody™ valved stent in tricuspid position in a 1-year-old infant. Catheter Cardiovasc Interv 2017;89: E84–E89. doi: 10.1002/ccd.26672.CrossRefGoogle Scholar
Alkhouli, M, Campsey, DM, Higgins, L, Badhwar, V, Diab, A, Sengupta, PP.Transcatheter closure of a sinus venosus atrial septal defect via transhepatic access. JACC Cardiovasc Interv 2018;11: e113–e115. doi: 10.1016/j.jcin.2018.02.021.CrossRefGoogle ScholarPubMed
Jolly, N, Dhar, G, Amin, Z.Transhepatic closure of patent foramen ovale. Catheter Cardiovasc Interv 2010;75: 56–59. doi: 10.1002/ccd.22193.Google ScholarPubMed
Shim, D, Lloyd, TR, Beekman, RH 3rd. Transhepatic therapeutic cardiac catheterization: a new option for the pediatric interventionalist. Catheter Cardiovasc Interv 1999; 47: 41–45.3.0.CO;2-Y>CrossRefGoogle ScholarPubMed
Ebeid, MR.Transhepatic vascular access for diagnostic and interventional procedures: techniques, outcome, and complications. Catheter Cardiovasc Interv 2007; 69: 594–606.CrossRefGoogle ScholarPubMed
Emmel, M, Sreeram, N, Pillekamp, F, Boehm, W, Brockmeier, K.Transhepatic approach for catheter interventions in infants and children with congenital heart disease. Clin Res Cardiol 2006; 95: 329–333.Google ScholarPubMed
McLeod, K, Houston, A, Richens, T, Wilson, N. Transhepatic approach for cardiac catheterisation in children: initial experience Heart 1999; 82: 694–696. doi: 10.1136/hrt.82.6.694CrossRefGoogle ScholarPubMed
Guyton, AC, Hall, JE.The liver as an organ. In: Textbook of Medical Physiology, 11th edn. Philadelphia: Saunders; 2006: 859–860.Google Scholar
Dollinger, M, Goessmann, H, Mueller-Wille, R, Wohlgemuth, WA, Stroszczynski, C, Heiss, P.Percutaneous transhepatic and transsplenic portal vein access: embolization of the puncture tract using amplatzer vascular plugs. Rofo 2014;186: 142–150. doi: 10.1055/s-0033-1350514.Google ScholarPubMed
Uller, W, Müller-Wille, R, Grothues, D, et al.Gelfoam for closure of large percutaneous transhepatic and transsplenic puncture tracts in pediatric patients. Rofo 2014; 186: 693–697. doi: 10.1055/s-0033-1355905.Google ScholarPubMed